Drug intelligence / Profile preview

Highly Purified Gonadotropins

Development stage: Unknown
Modality: Recombinant Proteins and Enzymes
Administration: Intramuscular, Subcutaneous

Overview

Highly Purified Gonadotropins are a class of pharmaceutical drugs comprising protein hormones such as Follicle Stimulating Hormone (FSH), Human Chorionic Gonadotropin (hCG), and Human Menopausal Gonadotropin (HMG). These preparations are primarily used in fertility treatments, specifically for controlled ovarian stimulation to promote follicular development and maturation, and to induce ovulation. They provide exogenous gonadotropin activity to support reproductive processes.

Other names: HP urinary FSHHP-hCGHP-HMG

Targets

LHCGR (Luteinizing hormone/choriogonadotropin receptor)FSHR (Follicle-stimulating hormone receptor)

Beyond the preview

Go deeper on Highly Purified Gonadotropins.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Highly Purified Gonadotropins.

Explore the full profile